---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-003330"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:43:57.993323+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# The Joint Corp. Q1 revenue $22.4M (+28% YoY); net loss $206K; adj. EBITDA $1.8M; updates guidance

## Summary
- Revenue $22.4M, up 28% YoY; system-wide sales $98.8M (+27%); comp sales +15%.
- Net loss $206K ($0.01/sh) vs net income $2.3M ($0.16 diluted) in Q1 2021.
- Adjusted EBITDA $1.8M, down from $3.5M; operating loss $176K vs profit $2.0M.
- Opened 31 clinics (27 franchised, 4 greenfield) – record Q1; total clinics 736.
- Guidance updated: FY rev $98-102M; adj. EBITDA $12-14M; 110-130 franchised openings.

## SEC filing metadata
- accession: 0001171843-22-003330
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000117184322003330/0001171843-22-003330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000117184322003330/f8k_050522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-003330
- JSON: https://secwatch.observer/filing/0001171843-22-003330.json
- Plain text: https://secwatch.observer/filing/0001171843-22-003330.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.